Home
Science & Technology
Publications

Publications:
Our Research

Filter

Filter

Research Area
Technology
Resource type
Category
224 results found
Jul 14, 2021
Poster
COVID-19
Accessing Non-Peer-Reviewed Preprint Literature from Various Servers: An Essential Library Resource to Support Vaccine Development During A Global Pandemic

During the Covid-19 pandemic, new information has been changing rapidly and there is significant lag time for new manuscripts to become fully published journal articles. Please download the summary and watch the corresponding video.

Glass, Sharon
View/Download
Jun 30, 2021
Publication
Novavax led
The New England Journal of Medicine
COVID-19
Safety and Efficacy of the NVX-CoV2373 Covid-19 Vaccine
Heath, Paul T., Galiza, Eva P., Baxter, David N. , et al.
View
May 25, 2021
Presentation
COVID-19
Novavax COVID-19 Program Update for ISV

Dr. Gregory Glenn's COVID-19 presentation for the International Society for Vaccines (ISV) May 2021.

Glenn, Gregory
View/Download
May 5, 2021
Publication
Novavax led
New England Journal of Medicine
COVID-19
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
Shinde, Vivek, Bhikha, Sutika, Hoosain, Zaheer, et al.
View
May 5, 2021
Publication
Collaborative
The Lancet
Malaria, Matrix-M® adjuvant
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial
Datoo, Mehreen S., Natama, Magloire H., Somé, Athanase, et al.
View
May 5, 2021
Publication
Novavax led
Pre-print
COVID-19, Seasonal influenza
Combination Respiratory Vaccine Containing Recombinant SARS-CoV-2 Spike and Quadrivalent Seasonal Influenza Hemagglutinin Nanoparticles with Matrix-M Adjuvant
Massare, Michael J., Patel, Nita, Zhou, Bin, et al.
View
May 4, 2021
Clinical trial protocol
COVID-19
Current Protocol for Phase 3 Clinical Trial of NVX-CoV2373 in the U.K.
View/Download
May 4, 2021
Presentation
COVID-19
Novavax COVID-19 Program Update for World Vaccine Congress

Dr. Gregory Glenn's presentation at the World Vaccine Congress Washington 2021.

Glenn, Gregory
View/Download
Apr 14, 2021
Publication
Novavax included/third party
Cell Host and Microbe
COVID-19
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
Shen, Xiaoying, Tang, Haili, McDanal, Charlene, et al.
View
Apr 13, 2021
Publication
Collaborative
Annals of Internal Medicine
COVID-19, Matrix-M® adjuvant
A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated
Follmann D, Fintzi J, Fay MP, et al.
View